Purdue’s Abuse-Deterrent Hydrocodone Doesn’t Signal Zohdyro’s Demise
This article was originally published in The Pink Sheet Daily
Executive Summary
Hysingla approval highlights limits of abuse-deterrent technology, FDA’s Janet Woodcock says, a strong indication the new abuse-deterrent competitor won’t force removal of the controversial drug from marketplace.